[
  {
    "ts": null,
    "headline": "GE HealthCare to Acquire Intelerad for $2.3B to Boost Cloud Imaging",
    "summary": "GEHC's $2.3B Intelerad deal aims to accelerate cloud imaging growth, expand outpatient reach and boost its shift toward high-margin SaaS revenue.",
    "url": "https://finnhub.io/api/news?id=60366e7d0672e284098e5146a77cb9069f0d0311eec5e7109c7e80021eb8cfed",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1764000540,
      "headline": "GE HealthCare to Acquire Intelerad for $2.3B to Boost Cloud Imaging",
      "id": 137591524,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "GEHC's $2.3B Intelerad deal aims to accelerate cloud imaging growth, expand outpatient reach and boost its shift toward high-margin SaaS revenue.",
      "url": "https://finnhub.io/api/news?id=60366e7d0672e284098e5146a77cb9069f0d0311eec5e7109c7e80021eb8cfed"
    }
  },
  {
    "ts": null,
    "headline": "Defibrillator Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts",
    "summary": "The global defibrillator market is forecasted to expand significantly, increasing from US$ 13.74 billion in 2024 to US$ 25.80 billion by 2033, with a steady CAGR of 7.25%. Key drivers include the proliferation of public access defibrillators, expanded ambulance services, and a surge in cardiac ailments. Defibrillators like AEDs and manual devices remain crucial in enhancing survival rates during cardiac arrest emergencies. Top players such as Medtronic, Boston Scientific, and Philips are pivotal",
    "url": "https://finnhub.io/api/news?id=7050c2a5cc6baced7b6f77d788cab7b251e146635b6838d6906d85fe4f124a8a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763999820,
      "headline": "Defibrillator Market Competitive Landscape Report 2025: Recent Developments, Company Strategies, Sustainability Benchmarking, Product Launches, Key Persons, and Revenue Forecasts",
      "id": 137591525,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The global defibrillator market is forecasted to expand significantly, increasing from US$ 13.74 billion in 2024 to US$ 25.80 billion by 2033, with a steady CAGR of 7.25%. Key drivers include the proliferation of public access defibrillators, expanded ambulance services, and a surge in cardiac ailments. Defibrillators like AEDs and manual devices remain crucial in enhancing survival rates during cardiac arrest emergencies. Top players such as Medtronic, Boston Scientific, and Philips are pivotal",
      "url": "https://finnhub.io/api/news?id=7050c2a5cc6baced7b6f77d788cab7b251e146635b6838d6906d85fe4f124a8a"
    }
  },
  {
    "ts": null,
    "headline": "Okami raises $45M to commercialize vascular embolization devices",
    "summary": "The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.",
    "url": "https://finnhub.io/api/news?id=6a3acda819d93ecce1389499106b0fb70bed67942c47dd0c5903f5ed09398eef",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763997360,
      "headline": "Okami raises $45M to commercialize vascular embolization devices",
      "id": 137592762,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.",
      "url": "https://finnhub.io/api/news?id=6a3acda819d93ecce1389499106b0fb70bed67942c47dd0c5903f5ed09398eef"
    }
  },
  {
    "ts": null,
    "headline": "BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now?",
    "summary": "Boston Scientific's EP breadth, WATCHMAN momentum and acquisitions give it an edge over Edwards in cardiovascular devices.",
    "url": "https://finnhub.io/api/news?id=abd35de9dd0f2d819d0020cb1699c58797a34355fc1acf44119bb61a7804d3db",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763990700,
      "headline": "BSX vs. EW: Which Heart Device Stock Is the Smarter Investment Now?",
      "id": 137591526,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific's EP breadth, WATCHMAN momentum and acquisitions give it an edge over Edwards in cardiovascular devices.",
      "url": "https://finnhub.io/api/news?id=abd35de9dd0f2d819d0020cb1699c58797a34355fc1acf44119bb61a7804d3db"
    }
  },
  {
    "ts": null,
    "headline": "Should You Hold Quest Diagnostics Stock in Your Portfolio for Now?",
    "summary": "DGX pushes growth through acquisitions and advanced diagnostics even as rising debt and tough competition pressure its outlook.",
    "url": "https://finnhub.io/api/news?id=b938d63eaf32737cbfcc9b98f6264278e3265bff8fe1885c8cd006b88d1755ab",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763988780,
      "headline": "Should You Hold Quest Diagnostics Stock in Your Portfolio for Now?",
      "id": 137591527,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "DGX pushes growth through acquisitions and advanced diagnostics even as rising debt and tough competition pressure its outlook.",
      "url": "https://finnhub.io/api/news?id=b938d63eaf32737cbfcc9b98f6264278e3265bff8fe1885c8cd006b88d1755ab"
    }
  }
]